José Guerreiro

Dr. José Guerreiro

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2020 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
MRMariana Romão
Mariana Romão
DFDébora Figueira
Débora Figueira
HGHeloísa Galante
Heloísa Galante
JGJosé Guerreiro
José Guerreiro
SRSónia Romano
Sónia Romano
Background: In 2017, ostomy patients gained access to ostomy products in community pharmacies that are fully reimbursed by the Portuguese National Health Service. This impacted the daily lives of people with ostomy and opened a new market of products and services for pharmacies. However, little is known about the sociodemographic and clinical profile of ostomy patients. This study aims to characterize people with ostomy and their caregivers, evaluate access and satisfaction with the pharmacy and explore participants’ expectations regarding services and counselling.Methods: This was an observational, cross-sectional, multicentre study involving pharmacy users who acquired ostomy products in Portuguese community pharmacies. Data were collected through a confidential self-report questionnaire between June and August 2019.Results: Approximately 56% of the participants were ostomy patients, of whom 65.9% were men. The average age of participating ostomy patients was 65.5 years old (SD = 12.9), and near 80% were retired/pensioners. Caregivers were mostly women (81.7%). More than half of the caregivers were employed and acquired products for a direct family member. Three in every four surgical interventions were consequences of cancer. Intestinal ostomy was the most common intervention (78.3%). More than 93% were satisfied with the acquisition of ostomy products at the pharmacy. Approximately 48.2% of ostomy patients received care from a specialized nurse.Conclusion: This study describes the profile of people with ostomy and their caregivers who attend community pharmacies in Portugal. Participants’ perceptions of the utility of different proposed services and pharmacist knowledge, as well as the low coverage of ostomy nursing care, highlight the opportunity for an extended role of pharmacists among this group.

1 May 2022 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
SRSónia Romano
Sónia Romano
JGJosé Guerreiro
José Guerreiro
ARAntónio Teixeira Rodrigues
António Teixeira Rodrigues

1 December 2018 in Primary Care Diabetes
Verified
Journal Article
Closed access
CTCarla Torre
Carla Torre
JGJosé Guerreiro
José Guerreiro
SRSónia Romano
Sónia Romano
AMAna Miranda
Ana Miranda
PLPatrícia Longo
Patrícia Longo
PLPedro Almeida Laires
Pedro Almeida Laires

21 March 2019 in Journal of Pharmaceutical Policy and Practice
Verified
Journal Article
Open access
PDF file
Suzete CostaSuzete Costa
Suzete Costa
MHMaria Rute Horta
Maria Rute Horta
RSRita Santos
Rita Santos
ZMZilda Mendes
Zilda Mendes
IJIsabel Jacinto
Isabel Jacinto
AMAna Paula Martins
Ana Paula Martins
Pharmacy-based interventions are complex public health endeavors which include, but are not restricted to, the conventional medication supply role. In diabetes, such interventions may improve patients’ outcomes. The aim of this study was to review relevant policies and research developed in Portugal directed at pharmacy-based diabetes interventions, and to inform future policies, practice and research in collaborative practice with primary care. An exploratory review of diabetes legislation and policy papers, as well as a comprehensive review in Embase, MEDLINE (via Ovid and PubMed), Google Scholar, and grey literature until November 2017 was performed. Sixteen policy papers and 10 studies were included in the analysis. Positive evidence from pharmacy interventions was retrieved concerning screening individuals at risk, screening uncontrolled patients, managing diabetes, and supporting self-monitoring. Some consistency in favorable findings, but also room for improvements in health policies, intervention design and research methods, were observed.

17 June 2010 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
EFE. Fontes
E. Fontes
JGJosé Guerreiro
José Guerreiro
TCT. Costa
T. Costa
AMA. Miranda
A. Miranda

Suzete CostaSuzete Costa
Suzete Costa
JBJosé Luís Biscaia
José Luís Biscaia
MHMaria Rute Horta
Maria Rute Horta
SRSónia Romano
Sónia Romano
JGJosé Guerreiro
José Guerreiro
DHDennis K. Helling
Dennis K. Helling
There is evidence of the efficacy of collaborative health interventions with pharmacies and primary care providers but little of its real-world effectiveness. We aimed to assess the effectiveness and discuss the design and challenges of hypertension and hyperlipidemia management between pharmacies and primary care providers using real-world data exchange between providers and experimental bundled payment. This was a pragmatic, quasi-experimental controlled trial. We collected patient-level data from primary care prescription claims and Electronic Medical Record databases, a pharmacy claims database, and patient telephone surveys at several time points. The primary outcomes were changes in blood pressure and total cholesterol. We used matched controls with difference-in-differences estimators in a Generalized Linear Model (GLM) and controlled interrupted time series (CITS). We collected additional data for economic and qualitative studies. A total of 6 Primary Care Units, 20 pharmacies, and 203 patients entered the study. We were not able to observe significant differences in the effect of intervention vs. control. We experienced challenges that required creative strategies. This real-world trial was not able to show effectiveness, likely due to limitations in the primary care technology which affected the sample size. It offers, however, valuable lessons on methods, strategies, and data sources, paving the way for more real-world effectiveness trials to advance value-based healthcare.